Quarter
Charts
πŸ‡ΊπŸ‡ΈUS Markets

Tesla, Inc.

TSLA

CIK 0001318605 Β· Quarterly mode Β· latest period FY2026 (Q1) (ending 2026-03-31) Β· sourced from SEC EDGAR

At a glance Β· FY2026 (Q1)

Revenue
$22.39B
↑+15.8% +$3.05Bvs FY2025 (Q1)
Operating Income
$941M
↑+135.8% +$542Mvs FY2025 (Q1)
Net Income
$477M
↑+243.2% +$338Mvs FY2025 (Q1)
Gross Profit
$4.72B
↑+49.7% +$1.57Bvs FY2025 (Q1)

Quality Score

Quality score

6-dimension fundamental snapshot Β· latest annual filed values Β· S&P 500 calibration

Average
51/100
  • Profitability
    0ROIC 3.6% (10% = solid, 20%+ = moat)
  • Liquidity
    77Current Ratio 2.04 (above 1.5 = solid)
  • Leverage
    95D/E 0.09 (under 0.5 = conservative)
  • Efficiency
    38Asset Turnover 0.70x (1.0+ = capital-efficient)
  • Growth
    69Revenue YoY +15.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    27Op Margin 4.2% Β· trend -1.4pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project TSLA's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -6.3%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≀ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$24.61
Total enterprise IV
$86.83B
Diluted shares
3.53B
Terminal PV
$61.19B (70% of total)
Year-5 FCF
$7.21B
YearProjected FCFDiscounted PV
+1$6.41B$5.82B
+2$6.60B$5.45B
+3$6.80B$5.11B
+4$7.00B$4.78B
+5$7.21B$4.48B
Terminal$98.55B$61.19B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target β€” and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation Β· trailing 4 quarters

how the company spent its cash
Capex (TTM)
$9.53B
investment in PP&E
Stock-based comp (TTM)
$3.28B
non-cash dilution

Balance sheet Β· 2026-03-31

latest filed snapshot
Total assets
$143.72B
everything owned
Total liabilities
$58.92B
everything owed
Stockholders' equity
$84.12B
shareholder claim
Net debt
$-8.96B
Net cash position ($8.96B)

Recent performance Β· 65 quarters

Revenue↑+15.8% +$3.05B
$22.39B
Net Income↑+16.6% +$68M
$477M
Free Cash Flow↑+117.5% +$780M
$1.44B
Operating Margin↑+2.1pts
4.2%

Drill down